Express Pharma

NOVEMBER 12, 2024

STEERLife, and Callidus Research Laboratories have forged a strategic partnership to accelerate drug development for global markets. T his partnership also enables end-to-end drug development for highly potent APIs.

Research Laboratories 97

Research Laboratories Drug Development 97

STAT

MARCH 8, 2024

Despite significant efforts, progress in psychiatric drug development has remained disappointingly slow. But the landscape remains predominantly marked by failures and a dry drug development pipeline. Approved drugs follow the same pattern of prescribing via guesswork, with most patients not responding to a given drug.

Drug Development 264

Drug Development 264

Drug Patent Watch

NOVEMBER 14, 2024

CROs have become integral partners for drug developers, providing expertise and resources to navigate the challenges of drug development… Source

Drug Development 85

Drug Development 85

STAT

SEPTEMBER 24, 2024

Generate:Biomedicines, a Flagship Pioneering company using artificial intelligence to create new medicines, announced today that it has struck a deal with Novartis to develop an undisclosed number of targets in various disease areas. With milestone payments, the company is eligible to receive over $1 billion, in addition to royalties.

Drug Development 284

Drug Development 284

STAT

SEPTEMBER 17, 2024

Psychiatric medicine hasn’t seen much innovation in recent decades, even as many say that drugs like psilocybin, MDMA, and DMT can offer real hope to millions of people who suffer from mental illnesses like post-traumatic stress disorder, depression, anxiety, and addiction.

Drug Development 286

Drug Development 286

STAT

MARCH 22, 2024

Drug development is more of a sprint than a marathon these days, thanks to more and better ways to target underlying biology and a more nuanced interpretation of precision medicine, three biotech leaders said at the STAT Breakthrough Summit East in New York Thursday.

Drug Development 322

Drug Development Vaccines 322

STAT

AUGUST 22, 2024

The pharmaceutical industry has long operated on a one-size-fits-all model, developing drugs primarily tested on, and thus best suited for, people of European descent. This approach ignores — and potentially harms — the billions of people of color on the planet.

Drug Development 297

Drug Development 297

Drug Patent Watch

NOVEMBER 20, 2024

Generic drug development is a complex process that involves rigorous scientific research and regulatory assessments. Food and Drug Administration (FDA) plays a crucial role in ensuring the quality and efficacy of generic drugs through various programs and guidelines.

Drug Development 52

Drug Development 52

pharmaphorum

OCTOBER 23, 2024

Patient insights play a critical role in shaping successful drug development. Learn how understanding the needs and experiences of patients can drive innovation and improve outcomes in the pharmaceutical industry.

Drug Development 104

Drug Development 104

STAT

JANUARY 8, 2024

Johnson & Johnson said Monday that it would purchase Ambrx Biopharma for nearly $2 billion, picking up a company specializing in targeted chemotherapy treatments — one of the hottest areas of cancer drug development.     The deal, disclosed as the biopharma field marked the first day of the annual J.P.

Drug Development 298

Drug Development Chemotherapy 298

Outsourcing Pharma

OCTOBER 29, 2024

In a move set to transform drug discovery, CRO NovAliX has partnered with Bruker, a leader in scientific instruments, through a strategic investment aimed at enhancing drug development success rates.

Drug Development 90

Drug Development 90

pharmaphorum

FEBRUARY 14, 2024

Discover how artificial intelligence (AI) is revolutionising the drug development process and transforming the way FDA-approved drugs are produced, ensuring compliance and optimising the supply chain. Learn more about the future of AI in pharmaceuticals.

Drug Development 128

Drug Development 128

Drug Patent Watch

NOVEMBER 18, 2024

This growth is driven by several factors, including the increasing prevalence of chronic diseases, cost-effectiveness, and patent expirations of branded drugs. The future of generic drug development in emerging markets looks promising, with technological advancements… Source

Drug Development 59

Drug Development 59

PharmaVoice

JANUARY 10, 2024

Although AI’s failure rates in drug development still leave room for improvement, today’s missteps feed tomorrow’s successes.

Drug Development 148

Drug Development 148

pharmaphorum

NOVEMBER 12, 2024

23andMe's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and sweeping job losses.The company that made its name by providing saliva-based genetic testing for health and ancestry to millions of people around the world made the decision as part of a major restructuring drive that will see 40% (..)

Drug Development 59

Drug Development 59

pharmaphorum

OCTOBER 24, 2024

Explore the future of drug development by integrating open source and commercial software. Learn how this innovative approach is revolutionising the field of drug discovery.

Drug Development 83

Drug Development 83

PharmaVoice

OCTOBER 26, 2022

The Stanford researcher and biotech entrepreneur discusses how click and bioorthogonal chemistry could revolutionize drug development.

Drug Development 265

Drug Development 265

Drug Patent Watch

OCTOBER 23, 2024

The pharmaceutical industry has faced significant challenges in recent years, including the loss of patents, increased regulatory scrutiny, and rising research and development costs. Patient centricity involves designing… Source

Drug Development 73

Drug Development 73

pharmaphorum

AUGUST 23, 2024

Discover how patient organizations play a key role in enabling drug development with the support of EFPIA. Learn more about their involvement and impact in the pharmaceutical industry.

Drug Development 110

Drug Development 110

STAT

OCTOBER 18, 2023

But at the STAT Summit on Wednesday, Daniel Skovronsky, the chief scientific and medical officer at Eli Lilly, discussed how Lilly has been able to crack both obesity and Alzheimer’s , two areas that have long stumped drug developers, and now two of the hottest commercial opportunities.

Drug Development 258

Drug Development 258

STAT

MARCH 15, 2023

STAT’s Matthew Herper struck an industry nerve when he wrote that the drug development industry is “not prepared for the next wave of biotech innovation.” ” His report ends on a somewhat dismal note: the industry is long on diagnosis (clinical development is too expensive) and short on cures.

Drug Development 237

Drug Development 237

PharmaVoice

OCTOBER 15, 2024

A Nobel Prize in chemistry for Google’s DeepMind protein-structure mapping is the tip of the iceberg for advances in drug discovery and development.

Drug Development 290

Drug Development 290

pharmaphorum

JULY 22, 2024

Rare Disease Diagnostics: Advancing Orphan Drug Development through Precision Testing Mike.Hammerton Mon, 22/07/2024 - 08:00 Bookmark this

Drug Development 111

Drug Development 111

European Pharmaceutical Review

JANUARY 11, 2024

Quotient Sciences leverage more than 30 years of drug development expertise to support small molecule and synthetic peptide drug programmes, in both simple drug programmes as well as complex cases where specialised formulation expertise and technologies are required.

Drug Development 111

Drug Development 111

STAT

OCTOBER 9, 2024

In the last year, pharma incumbents have leaned into partnerships with AI-driven startups to supercharge drug discovery efforts. High-powered models of protein structure and molecule binding can help identify new disease targets, and even help design new drugs.

Drug Development 307

Drug Development 307

pharmaphorum

NOVEMBER 1, 2024

The 8th Antigen-Specific Immune Tolerance Drug Development Summit is an event organised by Hanson Wade. Discover the latest developments and networking opportunities at this leading industry conference.

Immunization 52

Immunization Immunity Drug Development 52

Drug Patent Watch

SEPTEMBER 11, 2024

This innovative field has revolutionized the way drugs are developed, manufactured, and delivered to patients. One of the most promising applications of nanotechnology is in generic drug development, where it offers unparalleled opportunities to enhance efficacy, safety… Source

Drug Development 92

Drug Development 92

STAT

AUGUST 7, 2023

A behind-the-scenes feud over a drug development program erupted into public view as Nektar Therapeutics filed a lawsuit accusing Eli Lilly of undermining a project in favor of another deal.

Drug Development 213

Drug Development Drug Pricing 213

Drug Patent Watch

JULY 25, 2024

Developing a competitive edge in generic drug development is crucial for companies to gain a significant market share and dominate the market. Here are some key strategies and insights from industry…

Drug Development 95

Drug Development 95

pharmaphorum

JULY 17, 2024

Discover how artificial intelligence is revolutionising drug development and compliance in the pharmaceutical industry with these four impactful ways.

Drug Development 103

Drug Development 103

pharmaphorum

NOVEMBER 7, 2024

Welcome to the Molecular Glue Drug Development Summit! Mike.Hammerton Thu, 07/11/2024 - 09:15 Bookmark this

Drug Development 52

Drug Development 52

STAT

SEPTEMBER 3, 2024

Kathy Giusti was diagnosed with multiple myeloma in 1996, when she was a 37-year-old executive at the drug company G.D. The group has raised more than $600 million for research, launched nearly 100 clinical trials, and helped bring more than 15 new drugs to market. She was told she had three years to live.

Drug Development 361

Drug Development 361

Drug Patent Watch

JULY 31, 2024

The journey of a generic drug developer is a complex and multifaceted one, involving rigorous research, meticulous development, and stringent […] Source

Drug Development 82

Drug Development 82

European Pharmaceutical Review

JANUARY 2, 2024

Over the past several years, the pharmaceutical industry has faced challenges regarding quality assurance in drug development, the author asserted. It also lowers the regulatory burden too, the paper reported. [In

Drug Development 105

Drug Development Biosimilars Documentation 105

BioPharma Dive

OCTOBER 14, 2024

Choosing the right clinical outcome assessments (COAs) is an important part of successfully advancing drug development and securing regulatory approval.

Drug Development 52

Drug Development 52

pharmaphorum

JUNE 15, 2022

The 2nd NSCLC Drug Development Summit returns for its second year to unite biopharma and academic leaders during an exciting era of personalized medicine. Improve your drug development rationale across all lines of NSCLC and address challenges when moving therapies forward. Progress sequencing and combination approaches.

Drug Development 105

Drug Development Immunization Immunity 105

World Pharma News

AUGUST 22, 2024

AI can be used to predict the three-dimensional structures of important receptors and thereby speed up the development of potential drugs. In drug development, experimental methods are often used to determine the three-dimensional structures of target proteins and to understand how molecules bind to them.

Drug Development 69

Drug Development 69